SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-340078
Filing Date
2018-12-03
Accepted
2018-11-30 20:21:36
Documents
8
Period of Report
2018-11-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d667158d8k.htm 8-K 32225
2 EX-10.1 d667158dex101.htm EX-10.1 32588
3 EX-10.2 d667158dex102.htm EX-10.2 33978
4 EX-10.3 d667158dex103.htm EX-10.3 182694
5 EX-10.4 d667158dex104.htm EX-10.4 34835
6 EX-10.5 d667158dex105.htm EX-10.5 36921
7 EX-10.6 d667158dex106.htm EX-10.6 36041
8 GRAPHIC g667158dsp1.jpg GRAPHIC 3878
  Complete submission text file 0001193125-18-340078.txt   396224
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 181212599
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1